Status:
COMPLETED
Intrauterine Injection of Human Chorionic Gonadotrophin and Pregnancy Rate in ICSI
Lead Sponsor:
Ain Shams University
Conditions:
Repeated Implantation Failure
Eligibility:
FEMALE
20-35 years
Phase:
NA
Brief Summary
Despite recent advances in clinical and laboratory techniques of Assisted Reproductive Technology (ART), the pregnancy rate remains around 30% per cycle. It has been estimated that 50% to 75% of lost ...
Detailed Description
The endometrium can only support implantation during a discrete period of about 6 to 9 days after LH peak; termed the "window of implantation". During this period endometrial glandular epithelium is d...
Eligibility Criteria
Inclusion
- A- Age between 20 and 35 years old.
- B- Patients undergoing ICSI trial after one or more previous failure.
Exclusion
- A- Females with any local cause, uterine pathology, e.g: uterine myoma or previous myomectomy, endometriosis or the presence of hydrosalpinges.
- B- Patients undergoing ICSI trial for the first time.
- C- Previous Asherman Syndrome.
Key Trial Info
Start Date :
February 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03445910
Start Date
February 20 2018
End Date
July 30 2018
Last Update
August 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt